FDA Policy on CBD
Posted by Amy Abernethy, M.D., Ph.D., Principal Deputy Commissioner, and Lowell Schiller, J.D., Principal Associate Commissioner for Policy on Sep 17th 2019
FDA is Committed to Sound, Science-based Policy on CBD (7-17-2019)By: Amy Abernethy, M.D., Ph.D., Principal Deputy Commissioner, and Lowell Schiller, J.D., Principal Associate Commissioner for Policy